Cleared Traditional

K930129 - ARROW PICC-PERIPHERALLY INSERTED CENTRA...

K930129 is an FDA 510(k) clearance for ARROW PICC-PERIPHERALLY INSERTED CENTRA..., manufactured by Arrow Intl., Inc.. The device is a Class 2 General Hospital device with product code LJS cleared through the Traditional 510(k) pathway after a 440-day FDA review.

K930129 · Arrow Intl., Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1994
Decision
440d
Days
Class 2
Risk

K930129 is an FDA 510(k) clearance for the ARROW PICC-PERIPHERALLY INSERTED CENTRAL CATHETER. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Arrow Intl., Inc. (Reading, US). The FDA issued a Cleared decision on March 28, 1994 after a review of 440 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Arrow Intl., Inc. devices

FDA 510(k) Submission Details - K930129

510(k) Number K930129 FDA.gov
FDA Decision Cleared Substantially Equivalent - De Novo Granted (SEKD)
Date Received January 12, 1993
Decision Date March 28, 1994
Days to Decision 440 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
311d slower than avg
Panel avg: 129d · This submission: 440d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 190
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K930129.
DUAL LUMEN PERIPHERALLY INSERTED VENOUS CATHETER
K932430 · Pharmacia Deltec, Inc. · May 1994
PHERIPHERALLY INSERTED VENOUS CATHETER-Y SITE
K932433 · Pharmacia Deltec, Inc. · May 1994
PERIPHERALLYINSRTED VENOUS CATH. ALTERNATE CATH.
K932464 · Pharmacia Deltec, Inc. · May 1994
RIGHT ATRIAL CATHETER
K930630 · Akcess Medical Products, Inc. · Feb 1994
STRATO MEDICAL LIFEPORT LPS 7255 LOW PROFILE DUAL LUMEN VASCULAR ACCESS SYSTEM
K933884 · Strato Medical Corp. · Dec 1993
STRATO MEDICAL SINGLE LUMEN VALVED CATHETER
K924851 · Strato Medical Corp. · Dec 1993